Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Buy
27,500
+20,000
+267% +$205K 0.18% 71
2026
Q1
$82.1K Sell
7,500
-8,750
-54% -$163K 0.07% 71
2025
Q4
$321K Hold
16,250
0.27% 57
2025
Q3
$540K Buy
16,250
+5,250
+48% +$182K 0.45% 56
2025
Q2
$510K Sell
11,000
-1,000
-8% -$39.3K 0.46% 56
2025
Q1
$504K Buy
12,000
+1,000
+9% +$61.9K 0.51% 46
2024
Q4
$673K Buy
11,000
+5,000
+83% +$429K 0.6% 46
2024
Q3
$647K Hold
6,000
0.52% 53
2024
Q2
$828K Hold
6,000
0.76% 45
2024
Q1
$1.3M Buy
6,000
+4,750
+380% +$1.02M 1.1% 40
2023
Q4
$319K Sell
1,250
-125
-9% -$19.9K 0.26% 64
2023
Q3
$181K Hold
1,375
0.19% 63
2023
Q2
$457K Hold
1,375
0.45% 53
2023
Q1
$328K Buy
1,375
+750
+120% +$198K 0.39% 49
2022
Q4
$138K Buy
+625
New +$183K 0.16% 67

Other funds holding CRIS

CM Management's CRIS Position: Q2 2026 in Review

CM Management increased its Curis (CRIS) stake by 267% in Q2 2026, buying an estimated $205K and bringing the position to 27,500 shares worth $287K. The position accounts for 0.18% of the portfolio, ranked #71.

CM Management first reported a position in CRIS in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.3M in Q1 2024. 34 funds tracked by Wall St. Rank hold CRIS as of Q2 2026.

  • CM Management held 27,500 shares of Curis worth $287K as of Q2 2026.
  • CM Management bought 20,000 Curis shares in Q2 2026, an estimated $205K.
  • Curis made up 0.18% of CM Management's portfolio in Q2 2026, its #71 holding.
  • CM Management first reported a position in Curis in Q4 2022 and has held it in 15 quarters since.
  • CM Management's Curis position peaked at $1.3M in Q1 2024.
  • 34 funds tracked by Wall St. Rank held Curis as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.